Amgen Submits Biologics License Application To The FDA For Erenumab

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. NDAQ
9. CRM
10. CRWV

Go back to Amgen Submits Biologics License Application To The FDA For Erenumab
Amgen Inc (NASDAQ: AMGN) Delayed: 354.58 +0.52 (0.15%)
Previous Close $354.06    52 Week High $176.85 
Open $357.40    52 Week Low $133.64 
Day High $358.17    P/E 53.40 
Day Low $351.96    EPS $6.64 
Volume 813,740